Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Proliferative Diabetic Retinopathy (PDR) - Overview
Proliferative Diabetic Retinopathy (PDR) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Proliferative Diabetic Retinopathy (PDR) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Proliferative Diabetic Retinopathy (PDR) - Companies Involved in Therapeutics Development
Aerie Pharmaceuticals Inc
Antisense Therapeutics Ltd
Apexian Pharmaceuticals Inc
Boehringer Ingelheim Intertiol GmbH
Generium
Kubota Vision Inc
Kuur Therapeutics Ltd
Oxurion NV
Ribomic Inc
Samsung Bioepis Co Ltd
Proliferative Diabetic Retinopathy (PDR) - Drug Profiles
APX-3330 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AR-13503 SR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
atesidorsen sodium - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BI-764524 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
brolucizumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
emixustat hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ranibizumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ranibizumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RBM-008 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
THR-687 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Proliferative Diabetic Retinopathy (PDR) - Dormant Projects
Proliferative Diabetic Retinopathy (PDR) - Product Development Milestones
Featured News & Press Releases
May 08, 2016: Acucela Initiates Phase 2 Clinical Trial Addressing Proliferative Diabetic Retinopathy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Proliferative Diabetic Retinopathy (PDR), 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Proliferative Diabetic Retinopathy (PDR), 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Proliferative Diabetic Retinopathy (PDR) - Pipeline by Aerie Pharmaceuticals Inc, 2021
Proliferative Diabetic Retinopathy (PDR) - Pipeline by Antisense Therapeutics Ltd, 2021
Proliferative Diabetic Retinopathy (PDR) - Pipeline by Apexian Pharmaceuticals Inc, 2021
Proliferative Diabetic Retinopathy (PDR) - Pipeline by Boehringer Ingelheim International GmbH, 2021
Proliferative Diabetic Retinopathy (PDR) - Pipeline by Generium, 2021
Proliferative Diabetic Retinopathy (PDR) - Pipeline by Kubota Vision Inc, 2021
Proliferative Diabetic Retinopathy (PDR) - Pipeline by Kuur Therapeutics Ltd, 2021
Proliferative Diabetic Retinopathy (PDR) - Pipeline by Oxurion NV, 2021
Proliferative Diabetic Retinopathy (PDR) - Pipeline by Ribomic Inc, 2021
Proliferative Diabetic Retinopathy (PDR) - Pipeline by Samsung Bioepis Co Ltd, 2021
Proliferative Diabetic Retinopathy (PDR) - Dormant Projects, 2021